1. Home
  2. LEDS vs NCEL Comparison

LEDS vs NCEL Comparison

Compare LEDS & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$1.88

Market Cap

18.8M

Sector

Technology

ML Signal

HOLD

Logo NewcelX Ltd. Ordinary Shares

NCEL

NewcelX Ltd. Ordinary Shares

SELL

Current Price

$2.54

Market Cap

19.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LEDS
NCEL
Founded
2005
2008
Country
Taiwan
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8M
19.4M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
LEDS
NCEL
Price
$1.88
$2.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.5K
★ 14.3K
Earning Date
12-01-2026
09-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 53.12
N/A
EPS
★ 0.02
N/A
Revenue
★ $43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$92.00
★ N/A
Revenue Growth
★ 729.81
N/A
52 Week Low
$1.01
$1.83
52 Week High
$3.62
$5.12

Technical Indicators

Market Signals
Indicator
LEDS
NCEL
Relative Strength Index (RSI) 40.19 46.22
Support Level $1.85 $2.32
Resistance Level $2.52 $3.22
Average True Range (ATR) 0.24 0.25
MACD -0.04 0.01
Stochastic Oscillator 18.06 43.03

Price Performance

Historical Comparison
LEDS
NCEL

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

Share on Social Networks: